194 related articles for article (PubMed ID: 9356022)
1. GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner.
Suga S; Kanno T; Nakano K; Takeo T; Dobashi Y; Wakui M
Diabetes; 1997 Nov; 46(11):1755-60. PubMed ID: 9356022
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling.
Gromada J; Bokvist K; Ding WG; Holst JJ; Nielsen JH; Rorsman P
Diabetes; 1998 Jan; 47(1):57-65. PubMed ID: 9421375
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
Gromada J; Dissing S; Bokvist K; Renström E; Frøkjaer-Jensen J; Wulff BS; Rorsman P
Diabetes; 1995 Jul; 44(7):767-74. PubMed ID: 7789644
[TBL] [Abstract][Full Text] [Related]
4. cAMP-independent decrease of ATP-sensitive K+ channel activity by GLP-1 in rat pancreatic beta-cells.
Suga S; Kanno T; Ogawa Y; Takeo T; Kamimura N; Wakui M
Pflugers Arch; 2000 Aug; 440(4):566-72. PubMed ID: 10958340
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity.
Yada T; Itoh K; Nakata M
Endocrinology; 1993 Oct; 133(4):1685-92. PubMed ID: 8404610
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 modulates Ca2+ current but not K+ATP current in intact mouse pancreatic B-cells.
Britsch S; Krippeit-Drews P; Lang F; Gregor M; Drews G
Biochem Biophys Res Commun; 1995 Feb; 207(1):33-9. PubMed ID: 7857285
[TBL] [Abstract][Full Text] [Related]
7. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
Gromada J; Ding WG; Barg S; Renström E; Rorsman P
Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide.
Ding WG; Gromada J
Diabetes; 1997 Apr; 46(4):615-21. PubMed ID: 9075801
[TBL] [Abstract][Full Text] [Related]
9. Involvement of calmodulin in glucagon-like peptide 1(7-36) amide-induced inhibition of the ATP-sensitive K+ channel in mouse pancreatic beta-cells.
Ding WG; Kitasato H; Matsuura H
Exp Physiol; 2001 May; 86(3):331-9. PubMed ID: 11429650
[TBL] [Abstract][Full Text] [Related]
10. Activation of a cAMP-regulated Ca(2+)-signaling pathway in pancreatic beta-cells by the insulinotropic hormone glucagon-like peptide-1.
Holz GG; Leech CA; Habener JF
J Biol Chem; 1995 Jul; 270(30):17749-57. PubMed ID: 7543091
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP, a mediator of GLP-1, acts in concert with glucose and tolbutamide to increase cytosolic Ca2+ in pancreatic B-cells.
Yaekura K; Nakata M; Tanaka H; Yada T
Adv Exp Med Biol; 1997; 426():211-6. PubMed ID: 9544276
[No Abstract] [Full Text] [Related]
12. cAMP-signaling pathway acts in selective synergism with glucose or tolbutamide to increase cytosolic Ca2+ in rat pancreatic beta-cells.
Yaekura K; Kakei M; Yada T
Diabetes; 1996 Mar; 45(3):295-301. PubMed ID: 8593933
[TBL] [Abstract][Full Text] [Related]
13. GLP-1 (7-36) amide activates L-type Ca2+ channels of pancreatic B-cells through c-AMP signaling.
Suga S; Kanno T; Dobashi Y; Wakui M
Jpn J Physiol; 1997; 47 Suppl 1():S13-4. PubMed ID: 9266311
[No Abstract] [Full Text] [Related]
14. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).
Holz GG; Kühtreiber WM; Habener JF
Nature; 1993 Jan; 361(6410):362-5. PubMed ID: 8381211
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
Miura Y; Matsui H
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
[TBL] [Abstract][Full Text] [Related]
17. Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
Flamez D; Gilon P; Moens K; Van Breusegem A; Delmeire D; Scrocchi LA; Henquin JC; Drucker DJ; Schuit F
Diabetes; 1999 Oct; 48(10):1979-86. PubMed ID: 10512362
[TBL] [Abstract][Full Text] [Related]
18. [Ca2+]i-reducing action of cAMP in rat pancreatic beta-cells: involvement of thapsigargin-sensitive stores.
Yaekura K; Yada T
Am J Physiol; 1998 Feb; 274(2):C513-21. PubMed ID: 9486142
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells.
Tsuboi T; da Silva Xavier G; Holz GG; Jouaville LS; Thomas AP; Rutter GA
Biochem J; 2003 Jan; 369(Pt 2):287-99. PubMed ID: 12410638
[TBL] [Abstract][Full Text] [Related]
20. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors.
Moens K; Flamez D; Van Schravendijk C; Ling Z; Pipeleers D; Schuit F
Diabetes; 1998 Jan; 47(1):66-72. PubMed ID: 9421376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
